Trial in Progress: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Axatilimab and Corticosteroids as Initial Treatment for Moderate to Severe Chronic Graft-Versus-Host Disease

Abstract | Dec 6, 2025

Author

DeFilipp Z, et al.

Congress

American Society of Hematology Annual Meeting 2025

Orlando, Florida | Dec 6 – 9, 2025